sorafenib has been researched along with Peritoneal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadastik, Ü; Lavogina, D; Lavrits, A; Meltsov, A; Peters, M; Rinken, A; Salumets, A; Samuel, K; Sõritsa, D | 1 |
1 other study(ies) available for sorafenib and Peritoneal Diseases
| Article | Year |
|---|---|
Chemosensitivity and chemoresistance in endometriosis - differences for ectopic versus eutopic cells.
Topics: Adult; Aminobenzoates; Apoptosis; Caspase 3; Cell Survival; Cells, Cultured; Doxorubicin; Drug Resistance; Endometriosis; Endometrium; Epithelial Cells; Female; Humans; Necrosis; Oligopeptides; Oxadiazoles; Peritoneal Diseases; Sorafenib; Stromal Cells; Young Adult | 2019 |